Vortrag
Rational design and optimization of SGK1 inhibitors for the treatment osteoarthritis
Veranstaltungen
22.09.22
15:00 – 16:00
Medizinische Chemie
Dies ist ein Online Event
Dr. Nis Halland
Sanofi
The serine/threonine kinase SGK1 is an activator of the β-catenin pathway and a powerful stimulator of cartilage degradation that is found to be upregulated under genomic control in diseased osteoarthritic cartilage. Today no oral disease-modifying treatments are available and chronic treatment in this indication sets high requirements for the drug selectivity, pharmacokinetic and safety profile. We describe the preparation of a highly selective druglike 1H-pyrazolo[3,4-d]pyrimidine SGK1 inhibitor that matches both safety and pharmacokinetic requirements for oral dosing. Rational compound design was facilitated by a novel hSGK1 cocrystal structure and classic medicinal chemistry was applied to guide the chemical optimization of ADMET and selectivity profiles.
Kontaktperson
Alexander Lorey
Zu Ihrem Kalender hinzufügen
In andere Kalender herunterladen
Interessen
Medizinische Chemie
Veranstaltungsdetails
22.09.22
15:00 – 16:00
Medizinische Chemie
Dies ist ein Online Event
Dr. Nis Halland
Sanofi
Kontaktperson
Alexander Lorey
Zu Ihrem Kalender hinzufügen
In andere Kalender herunterladen
